DNA Methylation as a Biomarker for Cardiovascular Disease Risk

被引:289
|
作者
Kim, Myungjin [1 ,2 ]
Long, Tiffany I. [1 ,2 ]
Arakawa, Kazuko [1 ,2 ]
Wang, Renwei [3 ]
Yu, Mimi C. [3 ]
Laird, Peter W. [1 ,2 ]
机构
[1] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA
[2] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA
[3] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
来源
PLOS ONE | 2010年 / 5卷 / 03期
关键词
S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; EXPRESSION; HYPOMETHYLATION; ATHEROSCLEROSIS; PATTERNS; MICE;
D O I
10.1371/journal.pone.0009692
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). Methodology/Principal Findings: We examined the association between prevalence of CVD (myocardial infarction, stroke) and its predisposing conditions (hypertension, diabetes) and PBL global genomic DNA methylation as represented by ALU and Satellite 2 (AS) repetitive element DNA methylation in 286 participants of the Singapore Chinese Health Study, a population-based prospective investigation of 63,257 men and women aged 45-74 years recruited during 1993-1998. Men exhibited significantly higher global DNA methylation [geometric mean (95% confidence interval (CI)): 159 (143, 178)] than women [133 (121, 147)] (P= 0.01). Global DNA methylation was significantly elevated in men with a history of CVD or its predisposing conditions at baseline (P= 0.03) but not in women (P= 0.53). Fifty-two subjects (22 men, 30 women) who were negative for these CVD/predisposing conditions at baseline acquired one or more of these conditions by the time of their follow-up I interviews, which took place on average about 5.8 years post-enrollment. Global DNA methylation levels of the 22 incident cases in men were intermediate (AS, 177) relative to the 56 male subjects who remained free of CVD/predisposing conditions at follow-up (lowest AS, 132) and the 51 male subjects with a diagnosis of CVD or predisposing conditions reported at baseline (highest AS 184) (P for trend = 0.0008) No such association was observed in women (P = 0.91). Baseline body mass index was positively associated with AS in both men and women (P= 0.007). Conclusions/Significance: Our findings indicate that elevated, not decreased, PBL DNA methylation is positively associated with prevalence of CVD/predisposing conditions and obesity in Singapore Chinese.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] DNA methylation as a universal biomarker
    Levenson, Victor V.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (04) : 481 - 488
  • [32] ETHNIC-SPECIFIC DIFFERENCES IN REPEAT ELEMENT DNA METHYLATION AND CARDIOVASCULAR DISEASE RISK FACTORS
    Sulistyoningrum, D. C.
    Lear, S. A.
    Devlin, A. M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S303 - S303
  • [33] DNA Methylation as a Biomarker for Preeclampsia
    Anderson, Cindy M.
    Ralph, Jody L.
    Wright, Michelle L.
    Linggi, Bryan
    Ohm, Joyce E.
    BIOLOGICAL RESEARCH FOR NURSING, 2014, 16 (04) : 409 - 420
  • [34] Myeloperoxidase: A Useful Biomarker for Cardiovascular Disease Risk Stratification?
    Schindhelm, Roger K.
    van der Zwan, Leonard P.
    Teerlink, Tom
    Scheffer, Peter G.
    CLINICAL CHEMISTRY, 2009, 55 (08) : 1462 - 1470
  • [35] Early-life smoking, cardiovascular disease risk, and the mediating role of DNA methylation biomarkers of aging
    Chang Sheng
    Rui Zhou
    Hongcai Wang
    Guoqiang Lin
    Zhou Cai
    Wei Wang
    Journal of Translational Medicine, 23 (1)
  • [36] DNA methylation age as a biomarker for cancer
    Lau, Chung-Ho E.
    Robinson, Oliver
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (11) : 2652 - 2663
  • [37] DNA methylation, a biomarker for colorectal cancer
    Jubb, AM
    Quirke, P
    Oates, AJ
    EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 : 251 - 267
  • [38] DNA methylation as a biomarker in breast cancer
    Martens, John W. M.
    Margossian, Astrid L.
    Schmitt, Manfred
    Foekens, John
    Harbeck, Nadia
    FUTURE ONCOLOGY, 2009, 5 (08) : 1245 - 1256
  • [39] A DNA methylation biomarker of alcohol consumption
    Liu, C.
    Marioni, R. E.
    Hedman, A. K.
    Pfeiffer, L.
    Tsai, P-C
    Reynolds, L. M.
    Just, A. C.
    Duan, Q.
    Boer, C. G.
    Tanaka, T.
    Elks, C. E.
    Aslibekyan, S.
    Brody, J. A.
    Kuehnel, B.
    Herder, C.
    Almli, L. M.
    Zhi, D.
    Wang, Y.
    Huan, T.
    Yao, C.
    Mendelson, M. M.
    Joehanes, R.
    Liang, L.
    Love, S-A
    Guan, W.
    Shah, S.
    Mcrae, A. F.
    Kretschmer, A.
    Prokisch, H.
    Strauch, K.
    Peters, A.
    Visscher, P. M.
    Wray, N. R.
    Guo, X.
    Wiggins, K. L.
    Smith, A. K.
    Binder, E. B.
    Ressler, K. J.
    Irvin, M. R.
    Absher, D. M.
    Hernandez, D.
    Ferrucci, L.
    Bandinelli, S.
    Lohman, K.
    Ding, J.
    Trevisi, L.
    Gustafsson, S.
    Sandling, J. H.
    Stolk, L.
    Uitterlinden, A. G.
    MOLECULAR PSYCHIATRY, 2018, 23 (02) : 422 - 433
  • [40] A DNA methylation biomarker of alcohol consumption
    C Liu
    R E Marioni
    Å K Hedman
    L Pfeiffer
    P-C Tsai
    L M Reynolds
    A C Just
    Q Duan
    C G Boer
    T Tanaka
    C E Elks
    S Aslibekyan
    J A Brody
    B Kühnel
    C Herder
    L M Almli
    D Zhi
    Y Wang
    T Huan
    C Yao
    M M Mendelson
    R Joehanes
    L Liang
    S-A Love
    W Guan
    S Shah
    A F McRae
    A Kretschmer
    H Prokisch
    K Strauch
    A Peters
    P M Visscher
    N R Wray
    X Guo
    K L Wiggins
    A K Smith
    E B Binder
    K J Ressler
    M R Irvin
    D M Absher
    D Hernandez
    L Ferrucci
    S Bandinelli
    K Lohman
    J Ding
    L Trevisi
    S Gustafsson
    J H Sandling
    L Stolk
    A G Uitterlinden
    Molecular Psychiatry, 2018, 23 : 422 - 433